PER 2.44% 8.0¢ percheron therapeutics limited

isis set-back

  1. 4,661 Posts.
    lightbulb Created with Sketch. 701
    Probably now old news in here now, but, in case others are not aware:

    http://www.fiercebiotech.com/story/isis-dumps-rheumatoid-arthritis-effort-after-antisense-drug-flunks-phii/2013-08-05

    Important to remember still more pluses than negatives and we are doing our own thing - but interesting to always remember, we are in risk filled game and there will-be set-backs. Mind you, for RA I think there are better potential treatments (MSB) and for T2D (MSB).

    I still like where ANP is going - long-term!

    Just my views, I know nothing and always DYOR.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.